Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 1, 2009, Pages 9-18

  Madden, Krystal ^a   Flowers, Lisa ^b   Salani, Ritu ^b   Horowitz, Ira ^b   Logan, Sanjay ^b   Kowalski, Kevin ^c   Xie, Jun ^d   Mohammed, Sulma I ^a,c,e  

^a PURDUE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e Purdue University   (United States)

Author keywords

Cervical cancer; Cox 2; Curcumin

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOMA IN SITU; CELL CYCLE REGULATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CURCUMIN; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; HELA CELLS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PROTEOMICS; UTERINE CERVICAL NEOPLASMS;

EID: 59649118597     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.10.003     Document Type: Article

References (45)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer 94 (2001) 153-156
2. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83 (1990) 18-29
3. Eifel P.J., Burke T.W., Morris M., and Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol. 59 (1995) 38-44
4. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., and Parkin D.M. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer 75 (1998) 536-545
5. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J., and Parkin D.M. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int. J. Cancer 86 (2000) 429-435
6. Vinh-Hung V., Bourgain C., Vlastos G., Cserni G., De Ridder M., Storme G., and Vlastos A.T. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 7 164 (2007)
7. Kleine W., Rau K., Schwoeorer D., and Pfleiderer A. Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol. Oncol. 35 (1989) 145-149
8. Green J.A., and De Barros Lopes A. Optimizing treatment for cervical cancer. The value of chemoradiation. Am. J. Cancer 3 (2004) 215-227
9. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer: a systematic review and meta-analysis of individual patient data from 21 randomized controlled trials. Eur. J. Cancer 39 (2003) 2470-2486
10. Walboomers J., Jacobs M.V., Manos M., Bosch F.X., Kummer J.A., Shah K., Snijders P., Peto J., Meijer C., and Muñoz N. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
11. Andersson S., Rylander E., Larsson B., Strand A., Silfversvard C., and Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur. J. Cancer 37 (2001) 246-250
12. Bosch F X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
13. Munoz N., Bosch F.X., De Sanjose S., Herrero R., Castellsague X., Shah K V., Snijders P J., and Meijer C J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
14. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., Goldie S.J., Harper D.M., Kinney W., Moscicki A.B., Noller K.L., Wheeler C.M., Ades T., Andrews K.S., Doroshenk M.K., Kahn K.G., Schmidt C., Shafey O., Smith R.A., Partridge E.E., Gynecologic Cancer, Advisory Group, and GF. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J. Clin. 1 (2007) 7-28
15. Mahdavi A., and Monk B.J. Vaccines against human papillomavirus and cervical cancer: promises and challenges. The Oncologist 10 (2005) 528-538
16. Fossilien E. Molecular pathology of cyclooxygenase-2 in Neoplasia. Ann. Clin. Lab. Sci. 30 (2000) 3-21
17. Dannenberg A.J., Altorki N.K., Boyle J.O., Lin D.T., and Subbaramaiah K. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann. NY Acad. Sci. 952 (2001) 109-115
18. Subbaramaiah K., Telang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., and Dannenberg A.J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56 19 (1996) 4424-4429
19. Denkert C., Thoma A., Niesporek S., Weichert W., Koch I., Noske A., Schicktanz H., Burkhardt M., Jung K., Dietel M., and Kristiansen G. Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1. Prostate 67 4 (2007) 361-369
20. L'Espérance S., Popa I., Bachvarova M., Plante M., Patten N., Wu L., Têtu B., and Bachvarov D. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int. J. Oncol. 29 1 (2006) 5-24
21. Kutchera W., Jones D.A., Matsunami N., et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93 (1996) 4816-4820
22. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., and Ristimaki A. Expression of cyclooxygenase-2 in lung carcinoma. Cancer Res. 58 (1998) 4997-5001
23. Hwang D., Scollard D., Byrne J., and Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst. 90 (1998) 455-460
24. Mohammed S.I., Knapp D.W., Bostwick D.G., Foster R.S., Khan K.N., Woerner B.M., Snyder P.W., and Koki A.T. Expression of cyclooxygnase in human invasive transitional cell carcinoma (TCC) of the bladder. Cancer Res. 59 22 (1999) 5647-5650
25. Clark D.W., Layton D., and Shakir S.A. Do some inhibitors of COX-2 increase the risk of thromboembolic events: linking pharmacology with pharmacoepidemiology. Drug Saf. 27 (2004) 427-456
26. Couzin J. Drug safety. Withdrawal of Vioxx casts a shadow over cox-2 inhibitors. Science 306 (2004) 384-385
27. Divya C.S., and Pillai M.R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol. Carcinog. 45 5 (2006) 320-332
28. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., and Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J. Nanobiotechnol. 5 (2007)
29. Conney A.H., Lysz T., Ferraro T., Abidi T.F., Manchand P.S., Laskin J.D., and Huang M.T. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul. 31 (1991) 385-396
30. Johnson J., and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. (2007)
31. LoTempio M.M., Veena M.S., Steele H.L., Ramamurthy B., Ramalingam T.S., Cohen A.N., Chakrabarti R., Srivatsan E.S., and Wang M.B. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin. Cancer Res. 11 19 (2005) 6994-7002
32. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Finnegan-Olive T., Lou Y.R., Mitchell J.M., Laskin J.D., Newmark H., Yang C.S., et al. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13 6 (1992) 947-954
33. Huang M.T., Smart R.C., Wong C.Q., and Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48 21 (1988) 5941-5946
34. Lu Y.P., Chang R.L., Lou Y.R., Huang M.T., Newmark H.L., Reuhl K.R., and Conney A.H. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15 10 (1994) 2363-2370
35. Singh S.V., Haque A.K., Ahmad H., Medh R.D., and Awasthi Y.C. Glutathione S-transferase isoenzymes in human lung tumors. Carcinogenesis 9 9 (1988) 1681-1685
36. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., and Reddy B.S. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 59 3 (1999) 597-601
37. Inano H., Onoda M., Inafuku N., Kubota M., Kamada Y., Osawa T., Kobayashi H., and Wakabayashi K. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis 20 6 (1999) 1011-1018
38. Bell R., Kimpel M., Rodd Z., Strother W., Bai F., Peper C., Mayfield R., Lumen L., Crabb D., McBride W., and Witzmann F. Protein expression changes in the nucleus accumbens and amygdale of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. Alcohol (2006) 503-517
39. Nagai N., Tian X., Mukai K., Hirata E., Kusuda T., Shiroyama Y., Shigemasa K., and Ohama K. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy. Int. J. Mol. Med. 12 (2003) 709-714
40. Chen Y., Wang L., Wang P., Lai C., Yen M., Ng H., and Yuan C. High cyclooxygenase-2 expression in cervical adenocarcinomas. Gynecol. Oncol. 88 (2003) 379-385
41. Kulkarni S., Rader J.S., Zhang F., Liapis H., Koki A., Masferrer J., Subbaramaiah K., and Dannenberg A. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin. Cancer Res. 7 (2001) 429-434
42. Bruce B., Khanna G., Ren L., Landberg G., Jirstrom K., Powell C., Borczuk A., Keller E.T., Wojno K.J., Meltzer P., Baird K., McClatchey A., Bretscher A., Hewitt S.M., and Khanna C. Expression of cytoskeleton linker protein ezrin in human cancers. Clin. Exp. Metastasis 24 2 (2007) 69-78
43. Kato K., Ito H., Kamei K., and Iwamoto I. Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. Cell Stress Chaperones 3 3 (1998) 152-160
44. He P., Naka T., Serada S., Fujimoto M., Tanaka T., Hashimoto S., Shima Y., Yamadori T., Suzuki H., Hirashima T., Matsui K., Shiono H., Okumura M., Nishida T., Tachibana I., Norioka N., Norioka S., and Kawase I. Proteomics-based identification of a-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 98 (2007) 1234-1240
45. Heikkinen K., Rapakko K., Karppinen S., Erkko H., Sakari Knuutila S., Tuija Lundán T., Arto Mannermaa A., Børresen-Dale A., Borg A., Barkardottir R., Petrini J., and Winqvist R. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27 (2006) 1593-1599